Clearmind Medicine Common Stock Market Value
| CMND Stock | USD 1.30 0.02 1.56% |
| Symbol | Clearmind |
Clearmind Medicine Common Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Return On Assets (0.58) | Return On Equity (2.68) |
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Clearmind Medicine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clearmind Medicine's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clearmind Medicine.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Clearmind Medicine on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Clearmind Medicine Common or generate 0.0% return on investment in Clearmind Medicine over 720 days. Clearmind Medicine is related to or competes with DiaMedica Therapeutics, Lyra Therapeutics, and Centessa Pharmaceuticals. Clearmind Medicine is entity of United States More
Clearmind Medicine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clearmind Medicine's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clearmind Medicine Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.53 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 45.83 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 8.13 |
Clearmind Medicine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clearmind Medicine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clearmind Medicine's standard deviation. In reality, there are many statistical measures that can use Clearmind Medicine historical prices to predict the future Clearmind Medicine's volatility.| Risk Adjusted Performance | 0.0141 | |||
| Jensen Alpha | 0.0269 | |||
| Total Risk Alpha | (0.98) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.732 |
Clearmind Medicine Common Backtested Returns
Clearmind Medicine appears to be extremely dangerous, given 3 months investment horizon. Clearmind Medicine Common secures Sharpe Ratio (or Efficiency) of 0.0416, which signifies that the company had a 0.0416% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Clearmind Medicine Common, which you can use to evaluate the volatility of the firm. Please makes use of Clearmind Medicine's risk adjusted performance of 0.0141, and Mean Deviation of 3.65 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Clearmind Medicine holds a performance score of 3. The firm shows a Beta (market volatility) of 0.0445, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Clearmind Medicine's returns are expected to increase less than the market. However, during the bear market, the loss of holding Clearmind Medicine is expected to be smaller as well. Please check Clearmind Medicine's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether Clearmind Medicine's price patterns will revert.
Auto-correlation | 0.50 |
Modest predictability
Clearmind Medicine Common has modest predictability. Overlapping area represents the amount of predictability between Clearmind Medicine time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clearmind Medicine Common price movement. The serial correlation of 0.5 indicates that about 50.0% of current Clearmind Medicine price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.2 |
Clearmind Medicine Common lagged returns against current returns
Autocorrelation, which is Clearmind Medicine stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Clearmind Medicine's stock expected returns. We can calculate the autocorrelation of Clearmind Medicine returns to help us make a trade decision. For example, suppose you find that Clearmind Medicine has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Clearmind Medicine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Clearmind Medicine stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Clearmind Medicine stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Clearmind Medicine stock over time.
Current vs Lagged Prices |
| Timeline |
Clearmind Medicine Lagged Returns
When evaluating Clearmind Medicine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Clearmind Medicine stock have on its future price. Clearmind Medicine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Clearmind Medicine autocorrelation shows the relationship between Clearmind Medicine stock current value and its past values and can show if there is a momentum factor associated with investing in Clearmind Medicine Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Clearmind Medicine Common is a strong investment it is important to analyze Clearmind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearmind Medicine's future performance. For an informed investment choice regarding Clearmind Stock, refer to the following important reports:Check out Clearmind Medicine Correlation, Clearmind Medicine Volatility and Clearmind Medicine Alpha and Beta module to complement your research on Clearmind Medicine. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Clearmind Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.